TREAT-AHDS project elected for funding under the EUREKA-EUROSTARS framework

RTT announced today that its collaboration with Erasmus Medical Center in Rotterdam for the development of Emcitate® for the treatment of MCT8 deficiency (TREAT-AHDS) has been elected for a grant under the EUREKA-EUROSTARS framework. EUROSTARS is an EU framework for funding of innovative collaborations across borders which are near to market and have significant potential. Under the framework, the TREAT-AHDS project will receive matched funding of up to 1 MEUR over the course of the coming 3 years towards the continued development of Emcitate.

Leave a Reply

Your email address will not be published. Required fields are marked *